Skip to main content

Advertisement

Table 2 Association of IGT with the components of metabolic syndrome a

From: Metabolic syndrome and the early detection of impaired glucose tolerance among professionals living in Beijing, China: a cross sectional study

  Prevalence (%) Number of IGT (%) OR (95% CI) AROC (95% CI) AR % PAR %
MS-NCEP 309 (33.3) 129 (41.8) 3.16 (2.26-4.42) 63.4 (60.3-66.5) 64.0 37.2
MS-IDF 278 (30.0) 132 (42.1) 2.84 (2.03-3.97) 63.0 (60.0 -66.0) 61.6 32.5
Central obesity 489 (52.7) 158 (32.3) 2.06 (1.46-2.91) 58.9 (56.2-61.5) 54.9 39.1
Hyperglycemia 279 (30.1) 118 (42.3) 2.79 (1.99-3.91) 66.9 (61.5-72.3) 61.3 32.6
High TG 293 (31.6) 96 (32.8) 1.95 (1.39-2.74) 56.5 (53.4-59.6) 39.4 17.1
Low HDL-C 301 (32.4) 91 (30.2) 1.65 (1.19-2.30) 54.7 (51.6-57.7) 30.9 12.7
High BP 415 (44.7) 141 (34.0) 1.61 (1.13-2.30) 59.1 (56.3-62.9) 53.5 34.0
  1. aLogistic regression was age-and gender-adjusted. IGT: impaired glucose tolerance; MS: metabolic syndrome; NCEP: National Cholesterol Education Program; IDF: International Diabetes Federation; TG: triglycerides; HDL-C: high-density-lipoprotein cholesterol; BP: blood pressure; AROC: receiver-operating characteristic curve; AR %: Attributable risk percentage; PAR %: Population attributable risk percentage.